Course Format
Online
Course Duration
1 Month
Course Certification
GHA Certificate on completion
Course Fee
₹35,400/-
Including GST
Rad-Immune
About The Course
The understanding of the immune system is changing the way we treat different types of
cancer, and focused radiotherapy is an effective Immuno-sensitiser that can potentiate the
ability to fight cancer with technology.
Using the techniques of leading cancer researchers and oncologists, this unique online course teaches professionals about cutting-edge immunotherapies combined with radiation treatment.
The ability of radiotherapy to enhance the antigenicity and adjuvanticity of an irradiated tumour has stimulated interest in its combination with immuno-oncology agents. However, radiotherapy often generates multiple layers of host responses which likely depend on the tumour biology, the immune cell infiltration, and the induction of immunosuppressive signals post-radiotherapy.
Consequently, the translation of preclinical findings to the clinic is more convoluted than anticipated which underscores the need to decipher molecular and cellular mechanisms elicited by radiotherapy.
Here, we review pro-inflammatory and immunosuppressive mechanisms triggered by radiotherapy that impact the outcome of antigen-specific T-cell killing and discuss how radiation-induced immunostimulatory mechanisms can be exploited to reactivate the host’s immune system, especially in the context of immunotherapy and hence catapulting into a new age of “Immuno-Radiotherapy”.
Learning Objective:
The understanding of the immune system is changing the way we treat different types of cancer, and Focused Radiotherapy is an effective immuno-sensitizer that can potentiate the ability to fight cancer with technology. Using the techniques of leading cancer researchers and oncologists, this unique online course teaches professionals about cutting-edge immunotherapies combined with radiation treatment.
Using the techniques of leading cancer researchers and oncologists, this unique online course teaches professionals about cutting-edge immunotherapies combined with radiation treatment.
The ability of radiotherapy to enhance the antigenicity and adjuvanticity of an irradiated tumour has stimulated interest in its combination with immuno-oncology agents. However, radiotherapy often generates multiple layers of host responses which likely depend on the tumour biology, the immune cell infiltration, and the induction of immunosuppressive signals post-radiotherapy.
Consequently, the translation of preclinical findings to the clinic is more convoluted than anticipated which underscores the need to decipher molecular and cellular mechanisms elicited by radiotherapy.
Here, we review pro-inflammatory and immunosuppressive mechanisms triggered by radiotherapy that impact the outcome of antigen-specific T-cell killing and discuss how radiation-induced immunostimulatory mechanisms can be exploited to reactivate the host’s immune system, especially in the context of immunotherapy and hence catapulting into a new age of “Immuno-Radiotherapy”.
Learning Objective:
The understanding of the immune system is changing the way we treat different types of cancer, and Focused Radiotherapy is an effective immuno-sensitizer that can potentiate the ability to fight cancer with technology. Using the techniques of leading cancer researchers and oncologists, this unique online course teaches professionals about cutting-edge immunotherapies combined with radiation treatment.
Learning Methodology:
- Online interactive sessions.
- 2-week course – 1 hour each including the Q&A session
- Expert commentary on videos.
- Renowned oncologists with expertise in Immuno-Rad.
- Shared knowledge of translational research from the best labs working on Immuno-Rad concepts.
Learning Outcome:
- Ground-breaking original research conception gluing bench to bedside.
- An Unlearn-Relearn approach to the applications of current era Radiotherapy.
- Access to the best and latest research in Immuno radiotherapy combine.
Course Topics/Modules
Download Brochure For More Information
Meet our core team
DR. B.S AJAIKUMAR
EXECUTIVE CHAIRMAN
HCG HOSPITALS BENGALURU
DR. SHEKAR PATIL
SENIOR MEDICAL ONCOLOGIST
HCG HOSPITALS BENGALURU
DR. LOHITH REDDY
CONSULTANT RADIATION ONCOLOGIST
CLINICAL LEAD - RADIOMICS AND AI IN CANCER
HCG HOSPITALS
BENGALURU
DR. KRITHIKAA SEKAR
CONSULTANT RADIATION ONCOLOGIST
HCG HOSPITALS
BENGALURU